Core Viewpoint - Intelligent Bio Solutions Inc. (INBS) has entered a strategic alliance with Vlepis Pty Ltd to enhance its position in the consumer health monitoring market, leveraging both companies' technologies and expertise to accelerate the adoption of intelligent testing solutions [1][3]. Group 1: Strategic Alliance and Market Positioning - The partnership aims to combine INBS's non-invasive testing technologies with Vlepis's wearable solutions to enter the rapidly growing consumer health market, which is projected to expand significantly [1][3]. - Vlepis's wearable and software technologies complement INBS's existing products, including the Intelligent Fingerprinting Drug Testing Solution and the SMARTOX SmarTest Patch [1][3]. - The collaboration will focus on research and development, distribution network expansion, and leveraging regulatory expertise to expedite commercialization in key international markets [6]. Group 2: Market Growth and Demand - The global wearable medical devices market is valued at USD 42.7 billion in 2024 and is expected to grow at over 25% annually, reaching USD 168.3 billion by 2030, driving demand for non-invasive health solutions [2]. - The consumer healthcare sector is currently estimated at USD 383.7 billion and is projected to grow to USD 548.7 billion by 2030, indicating strong long-term revenue potential for INBS and Vlepis [3]. Group 3: Technological Integration and Innovation - The partnership allows INBS to evaluate Vlepis's proprietary technologies, which connect wearable devices to cloud-based platforms, enhancing the product ecosystem and customer value [3][4]. - The integration of INBS's Intelligent Fingerprinting System and SmarTest Patch with Vlepis's smart wearables could extend applications into both business-to-business-to-consumer and direct-to-consumer health markets [3][4]. - Vlepis's sensing solutions are designed for rapid customer deployment and adoption, supporting the digital transformation of health monitoring [4][5].

Company Overview - Intelligent Bio Solutions Inc. (INBS) is a medical technology company focused on delivering intelligent, rapid, non-invasive testing solutions [6] - The company aims to revolutionize portable testing through its Intelligent Fingerprinting Drug Screening System, which analyzes fingerprint sweat for drug use [6] Partnership and Product Expansion - INBS announced a global distribution agreement with SMARTOX® to introduce the SmarTest Patch drug detection product to international markets outside the U.S. and Canada [1][2] - The SmarTest Patch enhances INBS's product portfolio by providing continuous sweat-based drug detection over an extended period, targeting sectors such as justice and rehabilitation [2][3] Market Potential - The global drug testing market is projected to grow significantly, reaching approximately $18.6 billion by 2030, presenting new opportunities for INBS [2] - The partnership with SMARTOX supports INBS's international growth strategy and introduces an additional revenue stream aligned with its broader expansion goals [2] Regulatory Strategy - INBS is prioritizing securing FDA clearance for its fingerprint sweat-based drug testing technology for use beyond forensic settings as part of its U.S. expansion strategy [4] - The company is actively engaging with regulatory consultants and stakeholders to bring its innovative solution to market in the U.S. [4] Current Operations - INBS currently serves over 450 active accounts in 24 countries, providing non-invasive drug testing solutions across health, justice, and workplace sectors [3]

Core Insights - Intelligent Bio Solutions Inc. (INBS) will participate in the RISE25 conference, focusing on addiction, mental health, and justice innovation, which attracts over 7,000 attendees annually [1][3] - The company aims to showcase its Intelligent Fingerprinting Drug Testing Solution, which is currently utilized in the U.S. for forensic purposes through its partnership with SMARTOX [1][2] Company Overview - INBS is a medical technology company specializing in rapid, non-invasive testing solutions, with over 450 active accounts across 24 countries [1][4] - The Intelligent Fingerprinting Drug Screening System detects recent drug use through fingerprint sweat, providing results in under ten minutes, making it suitable for treatment courts and probation programs [2][6] Market Context - RISE25 serves as a national platform for professionals in public health and justice, focusing on evidence-based approaches for individuals affected by substance use and mental health issues [3][4] - The U.S. market for forensic use of drug testing presents significant expansion opportunities for INBS, which believes its technology can deliver substantial benefits in this sector [4] Strategic Partnerships - INBS collaborates with SMARTOX, a U.S.-based provider of drug and alcohol testing products, to enhance its market presence and support innovative solutions in various sectors [5][6] - The partnership aims to address the growing demand for reliable on-site drug testing solutions across workplaces, treatment facilities, and the justice system [1][4]